Critical Maine business news updated daily. Immediate access to all subscriber-only content on our website. Bi-weekly print or digital editions of our award-winning publication. Special bonus issues ...

Trastuzumab is a common treatment for various HER2-positive cancers. It is an antibody that specifically binds to HER2, a problematic protein over-expressed on cancer cells that signals for nonstop ...

Artificial Intelligence (AI) is entering a pivotal moment in healthcare. What began as a tool to assist providers with clinical documentation via ambient listening, is now evolving into something far ...

Understanding human gene function in living organisms has long been hampered by fundamental differences between species. Although mice share most protein-coding genes with humans, their regulatory ...

An enterprise employee is greeted by ‘Vikram’ as he loads an internal portal to create an IT ticket. Or a new hire’s guide in its HR portal is introduced as ‘Jenny.’ Names for virtual AI agents are ...

REYNOLDS, North Dakota – On days off from shift work, if Larry Gangle isn’t hunting, he’s fishing. And if he isn’t fishing, he’s hunting. An avid outdoorsman, born and raised in Oregon, he came from ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. Newly published research from mobile threat intelligence ...

In overseeing the expansion of the Islamic art galleries at the Metropolitan Museum, she countered hostile narratives about the Muslim world that arose after 9/11. By Jeré Longman See more of our ...

A fundamental challenge in preclinical research is accurately predicting human responses using conventional animal models. Traditional approaches often fail to adequately model human disease, creating ...

Efficacy and safety of dalpiciclib plus fulvestrant and pyrotinib in HR+, HER2-low advanced breast cancer following CDK4/6 inhibitor and aromatase inhibitor: A Bayesian optimal phase Ⅱ trial. This is ...

A recent study explored the therapeutic potential of hu128.1, a humanized antibody targeting transferrin receptor 1 (TfR1), in treating erythroleukemia using xenograft mouse models. The results ...